title: Tacrolimus effect on rosacea.
abstract: Twenty-four patients with erythrotelangiectatic or papulopustular rosacea were treated with 0.1% tacrolimus topical ointment in a 12-week open-label trial. Erythema was significantly improved in both rosacea subtypes (P<.05). There was no decrease in the number of papulopustular lesions. Side effects were consistent with those on the tacrolimus topical ointment labeling.
authors.affiliation: Dermatology Section, St. Mary's/Duluth Clinic Health System, MN 55805, USA. jbamford@smdc.org
authors.forename: Joel T M
authors.initials: JT
authors.lastname: Bamford
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Elliott
authors.forename: Irina V
authors.initials: IV
authors.lastname: Haller
mesh_terms: D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D012393:Rosacea / Q000188:drug therapy*; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus